NeueHealth (NEUE) Projected to Post Quarterly Earnings on Thursday

NeueHealth (NYSE:NEUE) will likely be posting its quarterly earnings results before the market opens on Thursday, March 20th. Analysts expect NeueHealth to post earnings of ($2.29) per share and revenue of $261.80 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

NeueHealth Stock Down 7.4 %

Shares of NYSE NEUE opened at $4.71 on Tuesday. NeueHealth has a 12 month low of $3.79 and a 12 month high of $7.66. The company has a market cap of $38.98 million, a price-to-earnings ratio of -0.09 and a beta of 0.56. The business has a fifty day simple moving average of $7.21 and a 200-day simple moving average of $6.01.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada dropped their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

Insider Activity

In related news, CEO George Lawrence Mikan III sold 31,798 shares of the stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $233,079.34. Following the completion of the sale, the chief executive officer now owns 146,539 shares in the company, valued at $1,074,130.87. This represents a 17.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jay Matushak sold 4,448 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the sale, the chief financial officer now owns 41,592 shares of the company’s stock, valued at $280,330.08. This represents a 9.66 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 110,033 shares of company stock valued at $774,560. Insiders own 64.30% of the company’s stock.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.